Literature DB >> 18687904

Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells.

Mary Poupot1, Jean-Jacques Fournié, Rémy Poupot.   

Abstract

Cross-regulations between innate immune cells have been given more and more emphasis. Here, we address the question of bidirectional interactions between activated monocytes and autologous NK cells. Classically activated monocytes (class-monocytes), obtained by priming with IFN-gamma, drive an inflammatory immune response. On the contrary, alternatively activated monocytes (alt-monocytes), obtained by stimulation with IL-4 or IL-13, engage an anti-inflammatory immune response. We show that alt-monocytes inhibit proliferation and production of IFN-gamma by autologous, IL-2-activated NK cells, whereas class-monocytes do not inhibit these NK cell functions. Reciprocally, IL-2-activated NK cells interact and undertake intensive synaptic transfer with alt-monocytes, whereas interactions with class-monocytes are weaker. This strong trogocytosis correlates with an efficient killing of alt-monocytes, mediated by natural cytotoxicity receptors and a lowered killing of class-monocytes. These results suggest that interactions between NK cells and autologous-activated monocytes modulate inflammatory responses. This might be extended further in the elimination of tumor-associated macrophages, which actively promote solid tumor progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687904     DOI: 10.1189/jlb.0508278

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

1.  Tumor-derived HLA-G1 acquisition by monocytes through trogocytosis: possible functional consequences.

Authors:  Channakeshava Sokke Umeshappa; Jim Xiang
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

2.  Trogocytosis-Mediated Intracellular Signaling in CD4+ T Cells Drives TH2-Associated Effector Cytokine Production and Differentiation.

Authors:  Jim Reed; Scott A Wetzel
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

3.  Assessing in vitro and in vivo Trogocytosis By Murine CD4+ T cells.

Authors:  Jim Reed; Scott A Wetzel
Journal:  Bio Protoc       Date:  2020-05-05

4.  Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions.

Authors:  Ronan Jambou; Valery Combes; Marie-Jose Jambou; Babeth B Weksler; Pierre-Olivier Couraud; Georges E Grau
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

5.  Enhanced cytotoxicity of natural killer cells following the acquisition of chimeric antigen receptors through trogocytosis.

Authors:  Fu-Nan Cho; Tsung-Hsien Chang; Chih-Wen Shu; Ming-Chin Ko; Shuen-Kuei Liao; Kang-Hsi Wu; Ming-Sun Yu; Shyh-Jer Lin; Ying-Chung Hong; Chien-Hsun Chen; Chien-Hui Hung; Yu-Hsiang Chang
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

6.  MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets.

Authors:  A Kurioka; J E Ussher; C Cosgrove; C Clough; J R Fergusson; K Smith; Y-H Kang; L J Walker; T H Hansen; C B Willberg; P Klenerman
Journal:  Mucosal Immunol       Date:  2014-10-01       Impact factor: 7.313

Review 7.  The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells.

Authors:  Séverine Fruchon; Rémy Poupot
Journal:  Molecules       Date:  2018-05-25       Impact factor: 4.411

8.  Hijacking TYRO3 from Tumor Cells via Trogocytosis Enhances NK-cell Effector Functions and Proliferation.

Authors:  Ting Lu; Rui Ma; Zhenlong Li; Anthony G Mansour; Kun-Yu Teng; Li Chen; Jianying Zhang; Tasha Barr; Michael A Caligiuri; Jianhua Yu
Journal:  Cancer Immunol Res       Date:  2021-07-29       Impact factor: 12.020

Review 9.  Mechanisms of cellular communication through intercellular protein transfer.

Authors:  Khawaja Ashfaque Ahmed; Jim Xiang
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.